Oral manifestations in myeloproliferative diseases: A literature review
DOI:
https://doi.org/10.33448/rsd-v10i5.14581Keywords:
Diagnosis; Hematological diseases; Hematology; Leukemia.; LeukemiaAbstract
Objective: to address the manifestations caused by the alterations caused by the various myeloproliferative diseases in the oral cavity and the implications in the patient's life, in order to provide a theoretical basis that helps in the early diagnosis and therapy of these pathologies. Materials and Methods: this is a literature review where a search was carried out in the databases related to the areas of Health such as: SCIELO, PUBMED and LILACS using time cut from 2016 to 2020, with the descriptors "hematology" or "diseases hematological "; "affection" or "oral manifestations" and "leukemia" or "hematological changes". Discussion: The present work is related to oral changes caused by myeloproliferative diseases, where there are few reports of these changes in the literature, since there was no knowledge of the involvement of the oral cavity with diseases, in an attempt to improve this differential diagnosis. This work brings the main alterations found in the literature on oral alterations. Conclusion: With this, the need for multidisciplinary monitoring of patients affected by these diseases is evident and it is hoped that this research, together with future research, can clarify the changes caused by myeloproliferative diseases, especially their manifestations in the oral cavity, for a differential diagnosis and precocious. Thus, we conclude that there is a direct relationship between clinical changes in the oral cavity in individuals with myeloproliferative disease.
References
Alshammasi, B., Albasry, Z., & Meshikhes, F. (2020). Oral hyperpigmentation associated with hydroxyurea in a patient with polycythemia vera: A case report. 8(10), 1904-1909. https://doi.org/10.1002/ccr3.3012.
Barbui, T. et al. (2017). Diagnostic impact of the 2016 revised who criteria for polycythemia vera. Am. J. Hematol. 92, 417–419. https://doi.org/10.1002/ajh.24684.
Boddu P. et al. (2017) Necrotizing fungal gingivitis in a patient with acute myelogenous leukemia: Visible yet obscure. Journal of Oral and Maxillofacial Surgery, 30 (1) 50-54. https://doi.org/10.1016/j.ajoms.2017.08.007.
Braun, L. M., & Zeiser, R. (2020). Immunotherapy in myeloproliferative diseases. Cells, 9(6), 1559. https://doi.org/10.3390/cells9061559.
Carvalho, J. S. et al. (2017). Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats. Journal of Periodontal Research, 52(5), 883-892. https://doi.org/10.1111/jre.12459.
Chinnasami, D. (2017). Idiopathic myelofibrosis in pregnancy-a rare case report. University Journal of Surgery and Surgical Specialities, 2(7).
Costa, S. S., Sousa, H. R., & Costa, I. S. (2017) O papel do cirurgião-dentista no diagnóstico precoce da leucemia e sua responsabilidade ética e legal–revisão de literatura. RBOL-Revista Brasileira de Odontologia Legal, 4(2). https://doi.org/10.21117/rbol.v4i2.82.
Couples (2018), Reproductive treatment of homosexual. diagnóstico de leucemia mieloide crônica em fase acelerada: relato de caso. Brasília Med, 55, 22-26. http://doi.org/10.5935/2236-5117.2018v55a02.
Eichstaedt, C. A. et al. (2020) Myeloproliferative diseases as possible risk factor for development of chronic thromboembolic pulmonary hypertension—A Genetic Study. International Journal of Molecular Sciences, 21(9), 3339. https://doi.org/10.3390/ijms21093339.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa: Artes Médicas.
Szuber, N. et al. (2020) Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management. American journal of hematology, 95(2), 212-224. https://doi.org/10.1002/ajh.25688
França, L. F. C. et al. (2017). Periodontitis changes renal structures by oxidative stress and lipid peroxidation. Journal of Clinical Periodontology, 44(6), 568-576. https://doi.org/10.1111/jcpe.12729.
Gomes‐filho, I. S. et al. (2020). Periodontitis and respiratory diseases: A systematic review with meta‐analysis. Oral diseases, 26(2), 439-446. https://doi.org/10.1111/odi.13228.
Haider, M. et al. (2016). Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET‐thrombosis) in 585 Mayo clinic patients. American Journal of Hematology, 91(4), 390-394. https://doi.org/10.1002/ajh.24293.
Houshmand, M. et al. (2019). Chronic myeloid leukemia stem cells. Leukemia, 33(7), 1543-1556. http://doi.org/10.1200/JCO.2008.17.5745.
Jabbour, E., & Kantarjian, H. (2018) Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. American journal of hematology, 93(3), 442-459. https://doi.org/10.1002/ajh.25011.
Kane, S. F. (2017). The effects of oral health on systemic health. Gen Dent, 65(6), 30-34. http://doi.org/10.1111/j.1834-7819.1999.tb00203.x.
Kumar, S. (2018). A case of choronic idiopathic myelofibrosis. University Journal of Medicine and Medical Specialities, 4(1).
Kvasnicka H. M. et al. (2017). European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia. Am. J. Hematol. 92, 1062–1067. https://doi.org/10.1002/ajh.24837.
Lago, C., & Petroni, T. F. (2017). Fisiopatologia e diagnóstico da Leucemia Mielóide Crônica. Revista Saúde UniToledo, 1(1).
Lee, Ji-Sook et al. (2020). S100A8 and S100A9 Promote apoptosis of chronic eosinophilic leukemia cells. Frontiers in immunology, 11, 1258. https://doi.org/10.3389/fimmu.2020.01258.
Maxson, J. E., & Tyner, J. W. (2017). Genomics of chronic neutrophilic leukemia. Blood, The Journal of the American Society of Hematology, 129(6), 715-722. https://doi.org/10.1182/blood-2016-10-695981.
Melo, B. S. L., & Gonçalves, D. S. S. (2016). Atuação do enfermeiro no tratamento da leucemia mielóide crônica. Revista Transformar, 9, 129-140.
Messadi, D. V., & Mirowski, G. W. (2019) Oral signs of hematologic disease. In: Oral Signs of Systemic Disease. Springer, Cham. p. 25-43. https://doi.org/10.1007/978-3-030-10863-2_3.
Morsia, E. et al. (2020). WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic. American journal of hematology, 95(7), E172-E174. https://doi.org/10.1002/ajh.25811.
Nussbaum G., & Shapira L. (2011) How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol. 38(11), 49–59. https://doi.org/10.1111/j.1600-051X.2010.01678.x.
Oliveira, K. K. V. et al. (2015). Manifestações Orais nas Doenças Hematológicas: revisão de literatura. Revista da Universidade Vale do Rio Verde, 13(2), 216-235. http://dx.doi.org/10.5892/ruvrd.v13i1.2275.
Oueslati, Y. et al. (2020). Oral lichen planus and polycythemia: possible association. Case Reports in Dentistry, v. 2020. https://doi.org/10.1155/2020/8820114.
Ouyang, Y. et al. (2017). Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Oncotarget, 8(13), 20834. https://dx.doi.org/10.18632%2Foncotarget.15355
Prasad, S. R. et al. (2018). Oral manifestations of myeloid neoplasms and acute leukemia-a diagnostic perspective. Hematol Transfus Int J, 6(5), 177-180. https://doi.org/10.15406/htij.2018.06.00177.
Ratre M. S. et al. (2018). Regular oral screening and vigilance: can it be a potential lifesaver?. J Indian Soc Periodontol. 22(3):171-173. https://dx.doi.org/10.4103%2Fjisp.jisp_136_18.
Rautenbach, Y., Goddard, A., & Clift, S. J. (2017). Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog. Veterinary clinical pathology, 46(1), 46-53. https://doi.org/10.1111/vcp.12430.
Raval, V., Sudana, P., & Taraprasad. (2019). Idiopathic myelofibrosis causing inflammatory central retinal vein occlusion mimicking frosted branch angiitis. BMJ Case Reports CP, 12(6), e229865. http://dx.doi.org/10.1136/bcr-2019-229865.
Regezi, J., Sciubba, J. J., & Jordan, R. C. K. (2017). Patologia oral: correlações clinicopatológicas. Elsevier Brasil.
Ribeiro, N. D. B. et al. (2021). Qualidade de vida de pacientes portadores de leucemia mieloide crônica tratados com mesilato de imatinibe. 2021.
Ruan, G. J. et al. (2020). A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States. American journal of hematology. https://doi.org/10.1002/ajh.25906.
Sampaio, J. A. M. et al. (2018). Leucemia mieloide aguda secundária à trombocitemia essencial na infância. Revista Científica Hospital Santa Izabel, 2(1), 37-42. https://doi.org/10.35753/rchsi.v2i1.84.
Shen Y. et al. (2018). Multifocal occurrence of intraoral isolated MS in a patient without leukemic presentation: A case report and literature review. Oral Medicine. 125(3):42-48. https://doi.org/10.1016/j.oooo.2017.11.013.
Shimizu R. et al. (2017). Unusual maxillary osteoblastic and osteolytic lesions presenting as an initial manifestation of childhood acute myeloid leukemia: A case report. Quintessence. 48(2):149-153. http://doi.org/10.3290/j.qia37383.
Sossela, F. R., Zoppas, B. C. A., & Weber, L. P. (2017). Leucemia Mieloide Crônica: aspectos clínicos, diagnóstico e principais alterações observadas no hemograma. RBAC, 49(2), 127-30. http://doi.org/10.21877/2448-3877.201700543.
Spivak, J. L. (2018). Polycythemia vera. Current treatment options in oncology, 19(2), 12. https://doi.org/10.1007/s11864-018-0529-x.
Spivak, J.L. (2017). Neoplasias mieloproliferativas. Engl. J. Med. 377, 895-896.
Szuber, N., & Tefferi, A. (2018). Chronic neutrophilic leukemia: new science and new diagnostic criteria. Blood cancer journal, 8(2), 1-19. http://doi.org/10.1038/s41408-018-0049-8.
Tag-Adeen M. et al. (2018). An unusual presentation of adult T-cell leukemia/lymphoma. Ecancermedicalscience. 12:801. https://dx.doi.org/10.3332%2Fecancer.2018.801.
Tangudu, B. A. et al. (2018). Oral manifestations associated with neutrophil deficiency and neutrophil disorders: A review. IAIM. 5(6): 61-71.
Tefferi, A. & Barbui, T. (2017). Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 92, 94–108. https://doi.org/10.1002/ajh.24607.
Tefferi, A., & Barbui, T. (2019) Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and management. American journal of hematology, 94(1), 133-143. https://doi.org/10.1002/ajh.25303.
Tefferi, A., Vannucchi, A. M., & Barbui, T. (2018). Polycythemia vera treatment algorithm 2018. Blood cancer journal, 8(1), 1-7. https://doi.org/10.1038/s41408-017-0042-7.
Thomas C. H., & Shapira, T. E. L. (1994). Van Dyke. Neutrophil defects as risk factors for periodontal disease. J Periodontol, 521-529. https://doi.org/10.1902/jop.1994.65.5s.521.
Vainchenker, W., & Kralovics, R. (2017). Base genética e fisiopatologia molecular de neoplasias mieloproliferativas clássicas. Sangue, 129, 667-679.
Vidyadharan, S., Joseph, B., & Nair, S. P. (2016). Chronic eosinophilic leukemia presenting predominantly with cutaneous manifestations. Indian journal of dermatology, 61(4), 437. https://dx.doi.org/10.4103%2F0019-5154.185716.
Zhao, H., & Deininger, M. W. (2020). Declaration of Bcr-Abl1 independence. Leukemia, p. 1-10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Hélio Mateus Silva Nascimento; Even Herlany Pereira Alves; Wesley Rodrigues da Silva; John Arlley Sousa Pinho de Lira; Francisco Alex da Rocha Coelho; Paulo Roberto Carneiro Gomes; Julyanne Maria Saraiva de Sousa; Mateus Cardoso do Amaral; Ayane Araújo Rodrigues; André dos Santos Carvalho; Thais Amanda de Lima Nunes; Samara Marques de Oliveira; Rubens Renato de Sousa Carmo; Daniel Fernando Pereira Vasconcelos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
